INVO Fertility, Inc. Common Stock (IVF) is a publicly traded Healthcare sector company. As of May 21, 2026, IVF trades at $1.61 with a market cap of $2.42M and a P/E ratio of 0.00. IVF moved +15.38% today. Year to date, IVF is -66.73%; over the trailing twelve months it is -99.36%. Its 52-week range spans $1.38 to $384.00. Rallies surfaces IVF's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
INVO Fertility Receives Nasdaq Deficiency Notice for Missing April 15 10-K: INVO Fertility received a Nasdaq deficiency notice on April 23 for missing its April 15, 2026 10-K filing covering the year ended December 31, 2025. The company has 60 days to submit a compliance plan and could secure up to 180 additional days if Nasdaq approves.
| Metric | Value |
|---|---|
| Price | $1.61 |
| Market Cap | $2.42M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $384.00 |
| 52-Week Low | $1.38 |
| Volume | 8.36K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
IVF analyst coverage data. Average price target: $0.00.